APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Syndrome Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dry Eye Syndrome Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025190 pages

Choose your research edition.

Industry ResearchDry Eye Syndrome Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Syndrome Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Dry Eye Syndrome Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Syndrome Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Syndrome Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Dry Eye Syndrome Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dry Eye Syndrome Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dry Eye Syndrome Drugs include Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, AbbVie, URSAPHARM, Thea pharmaceuticals, Sun Pharmaceutical and SIMILASAN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Dry Eye Syndrome Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Eye Syndrome Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Eye Syndrome Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Dry Eye Syndrome Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Eye Syndrome Drugs Segment by Company

Johnson & Johnson

Novartis

United Laboratories

Jianfeng Group

AbbVie

URSAPHARM

Thea pharmaceuticals

Sun Pharmaceutical

SIMILASAN

Santen Pharma

Rohto

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch & Lomb

Alcon

Akorn

Dry Eye Syndrome Drugs Segment by Type

Artificial Tears

Anti-inflammatory Drugs

Other

Dry Eye Syndrome Drugs Segment by Application

Homecare

Hospitals

Clinics

Others

Dry Eye Syndrome Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Syndrome Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Syndrome Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Syndrome Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Dry Eye Syndrome Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dry Eye Syndrome Drugs industry.

Chapter 3: Detailed analysis of Dry Eye Syndrome Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Eye Syndrome Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Artificial Tears Table 3. Key Players of Anti-inflammatory Drugs Table 4. Key Players of Other Table 4. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Homecare Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Key Players of Others Table 9. Global Dry Eye Syndrome Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Dry Eye Syndrome Drugs Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Dry Eye Syndrome Drugs Market Share by Region (2021-2026) Table 12. Global Dry Eye Syndrome Drugs Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Dry Eye Syndrome Drugs Market Share by Region (2027-2032) Table 14. Dry Eye Syndrome Drugs Industry Trends Table 15. Dry Eye Syndrome Drugs Industry Drivers Table 16. Dry Eye Syndrome Drugs Industry Opportunities and Challenges Table 17. Dry Eye Syndrome Drugs Industry Restraints Table 18. Global Dry Eye Syndrome Drugs Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Dry Eye Syndrome Drugs Revenue Market Share by Company (2021-2026) Table 20. Global Dry Eye Syndrome Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Dry Eye Syndrome Drugs Key Company Head Office and Area Served Table 22. Global Dry Eye Syndrome Drugs Company, Product Type & Application Table 23. Global Dry Eye Syndrome Drugs Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Dry Eye Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Dry Eye Syndrome Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2027-2032) Table 31. Global Dry Eye Syndrome Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2021-2026) Table 35. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2027-2032) Table 36. Johnson & Johnson Company Information Table 37. Johnson & Johnson Business Overview Table 38. Johnson & Johnson Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Johnson & Johnson Dry Eye Syndrome Drugs Product Portfolio Table 40. Johnson & Johnson Recent Development Table 41. Novartis Company Information Table 42. Novartis Business Overview Table 43. Novartis Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Novartis Dry Eye Syndrome Drugs Product Portfolio Table 45. Novartis Recent Development Table 46. United Laboratories Company Information Table 47. United Laboratories Business Overview Table 48. United Laboratories Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. United Laboratories Dry Eye Syndrome Drugs Product Portfolio Table 50. United Laboratories Recent Development Table 51. Jianfeng Group Company Information Table 52. Jianfeng Group Business Overview Table 53. Jianfeng Group Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Jianfeng Group Dry Eye Syndrome Drugs Product Portfolio Table 55. Jianfeng Group Recent Development Table 56. AbbVie Company Information Table 57. AbbVie Business Overview Table 58. AbbVie Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AbbVie Dry Eye Syndrome Drugs Product Portfolio Table 60. AbbVie Recent Development Table 61. URSAPHARM Company Information Table 62. URSAPHARM Business Overview Table 63. URSAPHARM Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. URSAPHARM Dry Eye Syndrome Drugs Product Portfolio Table 65. URSAPHARM Recent Development Table 66. Thea pharmaceuticals Company Information Table 67. Thea pharmaceuticals Business Overview Table 68. Thea pharmaceuticals Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Thea pharmaceuticals Dry Eye Syndrome Drugs Product Portfolio Table 70. Thea pharmaceuticals Recent Development Table 71. Sun Pharmaceutical Company Information Table 72. Sun Pharmaceutical Business Overview Table 73. Sun Pharmaceutical Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sun Pharmaceutical Dry Eye Syndrome Drugs Product Portfolio Table 75. Sun Pharmaceutical Recent Development Table 76. SIMILASAN Company Information Table 77. SIMILASAN Business Overview Table 78. SIMILASAN Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. SIMILASAN Dry Eye Syndrome Drugs Product Portfolio Table 80. SIMILASAN Recent Development Table 81. Santen Pharma Company Information Table 82. Santen Pharma Business Overview Table 83. Santen Pharma Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Santen Pharma Dry Eye Syndrome Drugs Product Portfolio Table 85. Santen Pharma Recent Development Table 86. Rohto Company Information Table 87. Rohto Business Overview Table 88. Rohto Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Rohto Dry Eye Syndrome Drugs Product Portfolio Table 90. Rohto Recent Development Table 91. Prestige Consumer Healthcare Company Information Table 92. Prestige Consumer Healthcare Business Overview Table 93. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product Portfolio Table 95. Prestige Consumer Healthcare Recent Development Table 96. OmniVision Pharma Company Information Table 97. OmniVision Pharma Business Overview Table 98. OmniVision Pharma Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. OmniVision Pharma Dry Eye Syndrome Drugs Product Portfolio Table 100. OmniVision Pharma Recent Development Table 101. LION Company Information Table 102. LION Business Overview Table 103. LION Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. LION Dry Eye Syndrome Drugs Product Portfolio Table 105. LION Recent Development Table 106. Kenvue (VISINE) Company Information Table 107. Kenvue (VISINE) Business Overview Table 108. Kenvue (VISINE) Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Kenvue (VISINE) Dry Eye Syndrome Drugs Product Portfolio Table 110. Kenvue (VISINE) Recent Development Table 111. Bausch & Lomb Company Information Table 112. Bausch & Lomb Business Overview Table 113. Bausch & Lomb Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Bausch & Lomb Dry Eye Syndrome Drugs Product Portfolio Table 115. Bausch & Lomb Recent Development Table 116. Alcon Company Information Table 117. Alcon Business Overview Table 118. Alcon Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Alcon Dry Eye Syndrome Drugs Product Portfolio Table 120. Alcon Recent Development Table 121. Akorn Company Information Table 122. Akorn Business Overview Table 123. Akorn Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Akorn Dry Eye Syndrome Drugs Product Portfolio Table 125. Akorn Recent Development Table 126. North America Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 127. North America Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 128. North America Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 129. North America Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 130. North America Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Dry Eye Syndrome Drugs Market Size by Country (2021-2026) Table 132. North America Dry Eye Syndrome Drugs Market Size by Country (2027-2032) Table 133. Europe Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 134. Europe Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 135. Europe Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 136. Europe Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 137. Europe Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Dry Eye Syndrome Drugs Market Size by Country (2021-2026) Table 139. Europe Dry Eye Syndrome Drugs Market Size by Country (2027-2032) Table 140. China Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 141. China Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 142. China Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 143. China Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 145. Asia Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 146. Asia Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 147. Asia Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Dry Eye Syndrome Drugs Market Size by Country (2021-2026) Table 150. Asia Dry Eye Syndrome Drugs Market Size by Country (2027-2032) Table 151. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Type (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Type (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Application (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Application (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021-2026) Table 157. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Dry Eye Syndrome Drugs Product Image Figure 2. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Dry Eye Syndrome Drugs Market Share by Type: 2025 VS 2032 Figure 4. Artificial Tears Image Figure 5. Anti-inflammatory Drugs Image Figure 6. Other Image Figure 7. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Dry Eye Syndrome Drugs Market Share by Application: 2025 VS 2032 Figure 9. Homecare Image Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Others Image Figure 13. Global Dry Eye Syndrome Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Dry Eye Syndrome Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Dry Eye Syndrome Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Dry Eye Syndrome Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Dry Eye Syndrome Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Dry Eye Syndrome Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Dry Eye Syndrome Drugs Market Share by Type (2021-2032) Figure 26. North America Dry Eye Syndrome Drugs Market Share by Application (2021-2032) Figure 27. North America Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 28. United States Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Dry Eye Syndrome Drugs Market Share by Type (2021-2032) Figure 33. Europe Dry Eye Syndrome Drugs Market Share by Application (2021-2032) Figure 34. Europe Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 35. Germany Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Dry Eye Syndrome Drugs Market Share by Type (2021-2032) Figure 43. China Dry Eye Syndrome Drugs Market Share by Application (2021-2032) Figure 44. Asia Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Dry Eye Syndrome Drugs Market Share by Type (2021-2032) Figure 46. Asia Dry Eye Syndrome Drugs Market Share by Application (2021-2032) Figure 47. Asia Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 48. Japan Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2021-2032) Figure 58. Brazil Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Dry Eye Syndrome Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other
Applications
  • Homecare
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • United Laboratories
  • Jianfeng Group
  • AbbVie
  • URSAPHARM
  • Thea pharmaceuticals
  • Sun Pharmaceutical
  • SIMILASAN
  • Santen Pharma
  • Rohto
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch & Lomb
  • Alcon
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Artificial Tears
  5. 1.2.3 Anti-inflammatory Drugs
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Homecare
  10. 1.3.3 Hospitals
  11. 1.3.4 Clinics
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Dry Eye Syndrome Drugs Growth Trends by Region
  15. 1.5.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Dry Eye Syndrome Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Dry Eye Syndrome Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Dry Eye Syndrome Drugs Market Dynamics
  1. 2.1 Dry Eye Syndrome Drugs Industry Trends
  2. 2.2 Dry Eye Syndrome Drugs Industry Drivers
  3. 2.3 Dry Eye Syndrome Drugs Industry Opportunities and Challenges
  4. 2.4 Dry Eye Syndrome Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Dry Eye Syndrome Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Dry Eye Syndrome Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Dry Eye Syndrome Drugs Key Company Head office and Area Served
  4. 3.4 Global Dry Eye Syndrome Drugs Company, Product Type & Application
  5. 3.5 Global Dry Eye Syndrome Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Dry Eye Syndrome Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Dry Eye Syndrome Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Dry Eye Syndrome Drugs Tier 1, Tier 2, and Tier 3
4 Dry Eye Syndrome Drugs Market by Type
  1. 4.1 Global Dry Eye Syndrome Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Dry Eye Syndrome Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Dry Eye Syndrome Drugs Market Size Share by Type (2021-2032)
5 Dry Eye Syndrome Drugs Market by Application
  1. 5.1 Global Dry Eye Syndrome Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Dry Eye Syndrome Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Dry Eye Syndrome Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Johnson & Johnson Dry Eye Syndrome Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Dry Eye Syndrome Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 United Laboratories
  14. 6.3.1 United Laboratories Company Information
  15. 6.3.2 United Laboratories Business Overview
  16. 6.3.3 United Laboratories Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 United Laboratories Dry Eye Syndrome Drugs Product Portfolio
  18. 6.3.5 United Laboratories Recent Developments
  19. 6.4 Jianfeng Group
  20. 6.4.1 Jianfeng Group Company Information
  21. 6.4.2 Jianfeng Group Business Overview
  22. 6.4.3 Jianfeng Group Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Jianfeng Group Dry Eye Syndrome Drugs Product Portfolio
  24. 6.4.5 Jianfeng Group Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AbbVie Dry Eye Syndrome Drugs Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 URSAPHARM
  32. 6.6.1 URSAPHARM Company Information
  33. 6.6.2 URSAPHARM Business Overview
  34. 6.6.3 URSAPHARM Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 URSAPHARM Dry Eye Syndrome Drugs Product Portfolio
  36. 6.6.5 URSAPHARM Recent Developments
  37. 6.7 Thea pharmaceuticals
  38. 6.7.1 Thea pharmaceuticals Company Information
  39. 6.7.2 Thea pharmaceuticals Business Overview
  40. 6.7.3 Thea pharmaceuticals Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Thea pharmaceuticals Dry Eye Syndrome Drugs Product Portfolio
  42. 6.7.5 Thea pharmaceuticals Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Dry Eye Syndrome Drugs Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 SIMILASAN
  50. 6.9.1 SIMILASAN Company Information
  51. 6.9.2 SIMILASAN Business Overview
  52. 6.9.3 SIMILASAN Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 SIMILASAN Dry Eye Syndrome Drugs Product Portfolio
  54. 6.9.5 SIMILASAN Recent Developments
  55. 6.10 Santen Pharma
  56. 6.10.1 Santen Pharma Company Information
  57. 6.10.2 Santen Pharma Business Overview
  58. 6.10.3 Santen Pharma Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Santen Pharma Dry Eye Syndrome Drugs Product Portfolio
  60. 6.10.5 Santen Pharma Recent Developments
  61. 6.11 Rohto
  62. 6.11.1 Rohto Company Information
  63. 6.11.2 Rohto Business Overview
  64. 6.11.3 Rohto Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Rohto Dry Eye Syndrome Drugs Product Portfolio
  66. 6.11.5 Rohto Recent Developments
  67. 6.12 Prestige Consumer Healthcare
  68. 6.12.1 Prestige Consumer Healthcare Company Information
  69. 6.12.2 Prestige Consumer Healthcare Business Overview
  70. 6.12.3 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product Portfolio
  72. 6.12.5 Prestige Consumer Healthcare Recent Developments
  73. 6.13 OmniVision Pharma
  74. 6.13.1 OmniVision Pharma Company Information
  75. 6.13.2 OmniVision Pharma Business Overview
  76. 6.13.3 OmniVision Pharma Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 OmniVision Pharma Dry Eye Syndrome Drugs Product Portfolio
  78. 6.13.5 OmniVision Pharma Recent Developments
  79. 6.14 LION
  80. 6.14.1 LION Company Information
  81. 6.14.2 LION Business Overview
  82. 6.14.3 LION Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 LION Dry Eye Syndrome Drugs Product Portfolio
  84. 6.14.5 LION Recent Developments
  85. 6.15 Kenvue (VISINE)
  86. 6.15.1 Kenvue (VISINE) Company Information
  87. 6.15.2 Kenvue (VISINE) Business Overview
  88. 6.15.3 Kenvue (VISINE) Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Kenvue (VISINE) Dry Eye Syndrome Drugs Product Portfolio
  90. 6.15.5 Kenvue (VISINE) Recent Developments
  91. 6.16 Bausch & Lomb
  92. 6.16.1 Bausch & Lomb Company Information
  93. 6.16.2 Bausch & Lomb Business Overview
  94. 6.16.3 Bausch & Lomb Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Bausch & Lomb Dry Eye Syndrome Drugs Product Portfolio
  96. 6.16.5 Bausch & Lomb Recent Developments
  97. 6.17 Alcon
  98. 6.17.1 Alcon Company Information
  99. 6.17.2 Alcon Business Overview
  100. 6.17.3 Alcon Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Alcon Dry Eye Syndrome Drugs Product Portfolio
  102. 6.17.5 Alcon Recent Developments
  103. 6.18 Akorn
  104. 6.18.1 Akorn Company Information
  105. 6.18.2 Akorn Business Overview
  106. 6.18.3 Akorn Dry Eye Syndrome Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Akorn Dry Eye Syndrome Drugs Product Portfolio
  108. 6.18.5 Akorn Recent Developments
7 North America
  1. 7.1 North America Dry Eye Syndrome Drugs Market Size (2021-2032)
  2. 7.2 North America Dry Eye Syndrome Drugs Market Size by Type
  3. 7.2.1 North America Dry Eye Syndrome Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Dry Eye Syndrome Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Dry Eye Syndrome Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Dry Eye Syndrome Drugs Market Size by Application
  7. 7.3.1 North America Dry Eye Syndrome Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Dry Eye Syndrome Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Dry Eye Syndrome Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Dry Eye Syndrome Drugs Market Size by Country
  11. 7.4.1 North America Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Dry Eye Syndrome Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Dry Eye Syndrome Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Dry Eye Syndrome Drugs Market Size (2021-2032)
  2. 8.2 Europe Dry Eye Syndrome Drugs Market Size by Type
  3. 8.2.1 Europe Dry Eye Syndrome Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Dry Eye Syndrome Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Dry Eye Syndrome Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Dry Eye Syndrome Drugs Market Size by Application
  7. 8.3.1 Europe Dry Eye Syndrome Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Dry Eye Syndrome Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Dry Eye Syndrome Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Dry Eye Syndrome Drugs Market Size by Country
  11. 8.4.1 Europe Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Dry Eye Syndrome Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Dry Eye Syndrome Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Dry Eye Syndrome Drugs Market Size (2021-2032)
  2. 9.2 China Dry Eye Syndrome Drugs Market Size by Type
  3. 9.2.1 China Dry Eye Syndrome Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Dry Eye Syndrome Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Dry Eye Syndrome Drugs Market Share by Type (2021-2032)
  6. 9.3 China Dry Eye Syndrome Drugs Market Size by Application
  7. 9.3.1 China Dry Eye Syndrome Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Dry Eye Syndrome Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Dry Eye Syndrome Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Dry Eye Syndrome Drugs Market Size (2021-2032)
  2. 10.2 Asia Dry Eye Syndrome Drugs Market Size by Type
  3. 10.2.1 Asia Dry Eye Syndrome Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Dry Eye Syndrome Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Dry Eye Syndrome Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Dry Eye Syndrome Drugs Market Size by Application
  7. 10.3.1 Asia Dry Eye Syndrome Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Dry Eye Syndrome Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Dry Eye Syndrome Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Dry Eye Syndrome Drugs Market Size by Country
  11. 10.4.1 Asia Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Dry Eye Syndrome Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Dry Eye Syndrome Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst